Trust and Regulation: Assuring Scientific Independence in the FDA’s Emergency Use Authorization Process

Patel NG, Kesselheim AS, Darrow JJ - Journal of Health Politics, Policy and Law

  • Regulation and Clinical Evidence

Summary:

Political interference in the FDA’s Emergency Use Authorization (EUA) process can undermine the agency’s scientific independence and public trust in FDA approval decisions. Expanding advisory committee involvement, increasing transparency around agency decision‑making, and better managing internal agency disagreement are all strategies the FDA should consider to improve the EUA process.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence